4.8 Article

HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism

期刊

JOURNAL OF CLINICAL INVESTIGATION
卷 118, 期 10, 页码 3431-3439

出版社

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI34823

关键词

-

资金

  1. Elizabeth Glaser Pediatric AIDS Foundation
  2. Bill and Melinda Gates Foundation
  3. Doris Duke Charitable Foundation
  4. Emerald Foundation
  5. Center for HIV/AIDS Vaccine Initiative [AI067854]
  6. NIH [AI0571278, AI044628, AI061684]
  7. Cancer Research institute

向作者/读者索取更多资源

Plasmacytoid DCs (pDCs) have been implicated as crucial cells in antiviral immune responses. On recognizing HIV, they become activated, secreting large amounts of IFN-alpha and inflammatory cytokines, thereby potentiating innate and adaptive antiviral immune responses. Here, we have shown that HIV-stimulated human pDCs can also induce the differentiation of naive CD4(+)T cells into Tregs with suppressive function. This differentiation was independent of pDC production of IFN-alpha and primarily dependent on pDC expression of indoleamine 2,3-dioxygenase, which was induced through the TLR/MyD88 pathway, following binding of HIV to CD4 and triggering of TLR7 by HIV genomic RNA. Functionally, the Tregs induced by pDCs were shown to inhibit the maturation of bystander conventional DCs. This study therefore reveals what we believe to be a novel mechanism by which pDC may regulate and potentially limit anti-HIV immune responses.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据